Endiya Partners

What is Endiya Partners?

Endiya Partners is an early-stage venture capital fund that focuses on investing in market-creating and category-defining companies with significant intellectual property that are globally relevant, particularly originating from India. With a deep belief in businesses built on robust fundamentals and a clear competitive advantage, they emphasize investments that are profitable and sustainable.

Their specializations include Enterprise, Healthcare & Life Sciences, Industrial Tech & Intelligent Mobility, and Fintech sectors, engaging in sectors where they foresee large and growing markets. Endiya strives to pinpoint well-defined problems and supports disruptive solutions, fostering deep customer relationships and backing strong teams with the potential to scale globally. As an Operator VC, Endiya brings a combination of deep domain expertise, extensive entrepreneurial experience, and a wide international network to realize their portfolio’s growth potential.

Their investments range from AI diagnosis, chronic disease management, cell therapy in the healthcare sector, to digital lending and equity management in Fintech; and in enterprise technology, they delve into digital enterprise and infosec technology. They take a thematic approach to investing, which combines with their collective experience in building and scaling companies allows for early identification of long-term market trends. They position themselves as a launchpad for early-stage product companies focused on enterprise, industrial tech, healthcare & life sciences.

Endiya Partners predominantly invests in seed and pre-series A rounds, retaining additional capital for follow-on rounds, which reflects their commitment to nurturing growth post-initial investment.

Their portfolio cumulatively includes innovative names such as AquaExchange, Darwinbox, Eyestem, Kissht, Mylo, Qapita, Scrut Automation, SigTuple, Sugar.Fit, and Zluri. They value swift decision-making to keep founders focused on building their companies, generally deciding on investments within a month and communicating promptly should they choose not to proceed.

What they say:

We partner with entrepreneurs to build product startups.

What we look for: We invest in early-stage startups across technology, healthcare, fintech, and deeptech.